ImmunoPrecise Antibodies Ltd

ImmunoPrecise Antibodies Ltd

IPA

Market Cap$50.8M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
ImmunoPrecise Antibodies LtdImmunoPrecise Antibodies Ltd-1.1--184%-0.6

Share Statistics

Market cap$50.80 Million
Enterprise Value$53.37 Million
Dividend Yield$0 (0%)
Earnings per Share$-1.06
Beta0.22
Outstanding Shares32,851,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-1.08
PEG-0.17
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue2.22
Enterprise Value to EBIT-1.5
Enterprise Value to Net Income-2
Total Debt to Enterprise0.29
Debt to Equity0.62

Revenue Sources

No data

Insider Trades

ESG Score

No data

About ImmunoPrecise Antibodies Ltd

2,021 employees

IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The...